person · Reporting owner

Strauss David P

Disclosed activity across 2 companies

Tapewire entity: 79523
SEC CIK: 0001705851

Reported relationships

Latest disclosed role at each company.

Company	Last reported as	Report date	Published
LINDE PLCLIN · Entity 2835	Executive VP, Chief HR Officer	May 16, 2025	May 20, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

LINDE PLC

Report date May 16, 2025 · Filed May 20, 2025

Security / award	Ownership account	Disclosed shares / units	Disclosure context
Ordinary SharesSEC Table I · non-derivative	IndirectIn Family Trust	22,639.04	Reported balance After 2025-05-16 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2025-05-16 · Sale · Disposed 1,987.16 · Balance 22,639.04 F1: The price reported is the weighted average sale price per share. The sale prices ranged from $456.94 to $457.14 per share. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.
Ordinary SharesSEC Table I · non-derivative	Direct	4,688.993	Reported balance Holding disclosure · report date 2025-05-16 · row 2 Holding and transaction disclosures are not merged. 1 source row Row 2 · Balance 4,688.993
Ordinary SharesSEC Table I · non-derivative	Indirect401(k)	1,949.383	Reported balance Holding disclosure · report date 2025-05-16 · row 3 Holding and transaction disclosures are not merged. 1 source row Row 3 · Balance 1,949.383
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	1,278	Reported balance Holding disclosure · report date 2025-05-16 · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · Balance 1,278 F2: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	1,235	Reported balance Holding disclosure · report date 2025-05-16 · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · Balance 1,235 F3: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.
Restricted Stock UnitsSEC Table II · derivative / convertible security	Direct	1,290	Reported balance Holding disclosure · report date 2025-05-16 · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · Balance 1,290 F4: Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $468.77 · Expires 2035-03-07	Direct	8,973	Reported balance Holding disclosure · report date 2025-05-16 · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · Balance 8,973 F5: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $465.29 · Expires 2034-03-07	Direct	8,010	Reported balance Holding disclosure · report date 2025-05-16 · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · Balance 8,010 F6: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $354.14 · Expires 2033-03-07	Direct	8,515	Reported balance Holding disclosure · report date 2025-05-16 · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · Balance 8,515 F7: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $270.99 · Expires 2032-03-07	Direct	10,200	Reported balance Holding disclosure · report date 2025-05-16 · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · Balance 10,200 F8: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $253.68 · Expires 2031-03-08	Direct	15,925	Reported balance Holding disclosure · report date 2025-05-16 · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · Balance 15,925 F9: This option vested in full over three years beginning on March 8, 2022.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $173.13 · Expires 2030-03-09	Direct	20,870	Reported balance Holding disclosure · report date 2025-05-16 · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · Balance 20,870 F10: This option vested in full over three years beginning on March 9, 2021.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $176.63 · Expires 2029-03-20	Direct	20,985	Reported balance Holding disclosure · report date 2025-05-16 · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · Balance 20,985 F11: This option vested in full over three years beginning March 20, 2020.
Stock Options (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2028-02-27	Direct	7,545	Reported balance Holding disclosure · report date 2025-05-16 · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · Balance 7,545 F12: This option vested in full over three years beginning on February 27, 2019.
Deferred Stock UnitsSEC Table II · derivative / convertible security	Direct	276.362	Reported balance Holding disclosure · report date 2025-05-16 · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · Balance 276.362 F13: Conversion to Linde plc Ordinary Shares is on a one-to-one basis. F14: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.

Filing footnotes · ownership attribution and instrument terms

F1: The price reported is the weighted average sale price per share. The sale prices ranged from $456.94 to $457.14 per share. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price.

F2: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis.

F3: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis.

F4: Restricted Stock Units that will vest in full and payout on or about March 7, 2026 in Linde plc Ordinary Shares on a one-for-one basis.

F5: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026.

F6: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025.

F7: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2024.

F8: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2023.

F9: This option vested in full over three years beginning on March 8, 2022.

F10: This option vested in full over three years beginning on March 9, 2021.

F11: This option vested in full over three years beginning March 20, 2020.

F12: This option vested in full over three years beginning on February 27, 2019.

F13: Conversion to Linde plc Ordinary Shares is on a one-to-one basis.

F14: Deferred stock units acquired under the Linde Compensation Deferral Plan as amended ("Plan"). The deferred stock units will payout in Linde plc Ordinary Shares on a one-for-one basis in accordance with the Plan.

Past disclosures · reporting ended (1)

No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.

PRAXAIR INC

Report date October 31, 2018 · Filed November 02, 2018

Section 16 reporting ended · disclosed 2018-11-02. Current position is not established by this disclosure.

Security / award	Ownership account	Disclosure context
Common StockSEC Table I · non-derivative	Indirect401(k)	Reported balance After 2018-10-31 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged. 1 source row Row 1 · 2018-10-31 · Disposition to issuer · Disposed 1,625.6827 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Common StockSEC Table I · non-derivative	Direct	Reported balance After 2018-10-31 transaction · row 2 1 source row Row 2 · 2018-10-31 · Disposition to issuer · Disposed 8,778.943 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 3 Instrument identity requires review; Table II rows are not merged. 1 source row Row 3 · 2018-10-31 · Disposition to issuer · Disposed 2,720 · Balance 0 F2: Restricted Stock Units ("RSUs") that were previously awarded by Praxair, Inc. that will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 4 Instrument identity requires review; Table II rows are not merged. 1 source row Row 4 · 2018-10-31 · Disposition to issuer · Disposed 570 · Balance 0 F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 5 Instrument identity requires review; Table II rows are not merged. 1 source row Row 5 · 2018-10-31 · Disposition to issuer · Disposed 2,168 · Balance 0 F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 6 Instrument identity requires review; Table II rows are not merged. 1 source row Row 6 · 2018-10-31 · Disposition to issuer · Disposed 585 · Balance 0 F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Restricted Stock UnitsSEC Table II · derivative / convertible security · Conversion / exercise price $0.00	Direct	Reported balance After 2018-10-31 transaction · row 7 Instrument identity requires review; Table II rows are not merged. 1 source row Row 7 · 2018-10-31 · Disposition to issuer · Disposed 1,490 · Balance 0 F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis. F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $60.92 · Expires 2019-02-24	Direct	Reported balance After 2018-10-31 transaction · row 8 Instrument identity requires review; Table II rows are not merged. 1 source row Row 8 · 2018-10-31 · Disposition to issuer · Disposed 5,220 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $76.16 · Expires 2020-02-23	Direct	Reported balance After 2018-10-31 transaction · row 9 Instrument identity requires review; Table II rows are not merged. 1 source row Row 9 · 2018-10-31 · Disposition to issuer · Disposed 3,070 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $97.84 · Expires 2021-02-22	Direct	Reported balance After 2018-10-31 transaction · row 10 Instrument identity requires review; Table II rows are not merged. 1 source row Row 10 · 2018-10-31 · Disposition to issuer · Disposed 3,630 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $109.68 · Expires 2022-02-28	Direct	Reported balance After 2018-10-31 transaction · row 11 Instrument identity requires review; Table II rows are not merged. 1 source row Row 11 · 2018-10-31 · Disposition to issuer · Disposed 4,610 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $110.58 · Expires 2023-02-26	Direct	Reported balance After 2018-10-31 transaction · row 12 Instrument identity requires review; Table II rows are not merged. 1 source row Row 12 · 2018-10-31 · Disposition to issuer · Disposed 4,255 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.80 · Expires 2024-02-25	Direct	Reported balance After 2018-10-31 transaction · row 13 Instrument identity requires review; Table II rows are not merged. 1 source row Row 13 · 2018-10-31 · Disposition to issuer · Disposed 4,305 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $128.38 · Expires 2025-02-24	Direct	Reported balance After 2018-10-31 transaction · row 14 Instrument identity requires review; Table II rows are not merged. 1 source row Row 14 · 2018-10-31 · Disposition to issuer · Disposed 5,150 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $102.22 · Expires 2026-02-23	Direct	Reported balance After 2018-10-31 transaction · row 15 Instrument identity requires review; Table II rows are not merged. 1 source row Row 15 · 2018-10-31 · Disposition to issuer · Disposed 7,955 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $118.71 · Expires 2027-02-28	Direct	Reported balance After 2018-10-31 transaction · row 16 Instrument identity requires review; Table II rows are not merged. 1 source row Row 16 · 2018-10-31 · Disposition to issuer · Disposed 19,815 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.
Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $154.00 · Expires 2028-02-27	Direct	Reported balance After 2018-10-31 transaction · row 17 Instrument identity requires review; Table II rows are not merged. 1 source row Row 17 · 2018-10-31 · Disposition to issuer · Disposed 22,635 · Balance 0 F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc. F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Filing footnotes · ownership attribution and instrument terms

F1: Reflects the disposition of Praxair common stock in connection with the consummation of the transactions contemplated by the Business Combination Agreement (the "BCA") dated as of June 1, 2017, by and among Linde Aktiengesellschaft, Praxair, Inc., a Delaware corporation (the "Company"), Linde plc, Zamalight Holdco LLC, and Zamalight Subco, Inc. (the "Business Combination"). In connection with the BCA, Praxair, Inc. became an indirect wholly-owned subsidiary of Linde plc, and each share of Praxair Common Stock, par value $0.01 per share, was exchanged for one Ordinary Share of Linde plc.

F2: Restricted Stock Units ("RSUs") that were previously awarded by Praxair, Inc. that will vest 100% on February 27, 2021. In connection with the BCA, the RSUs have been converted into RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F3: Restricted Stock Units previously awarded by Praxair, Inc. on February 23, 2016 that will vest and payout on February 23, 2019. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F4: Restricted Stock Units previously awarded by Praxair, Inc. on February 28, 2017 that will vest and payout on February 28, 2020. In connection with the BCA, the RSUs were converted to RSUs of Linde plc Ordinary Shares on a one-for-one basis.

F5: This option became exercisable in three (3) equal annual installments beginning on the first anniversary of the date of grant. and was fully vested and exercisable. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F6: This options vests over three years in three consecutive equal annual installments beginning on February 23, 2017. In accordance with the Buiness Combination Agreement , each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F7: This option vests over three years in three consecutive equal annual installments beginning on February 28, 2018. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

F8: This option vests over three years in three consecutive equal annual installments beginning on February 27, 2019. In accordance with the Business Combination Agreement, each stock option of Praxair outstanding immediately prior to the effective date of the Business Combination (whether vested or unvested) was automatically converted into an option to purchase shares of Linde plc ordinary shares equal to the total number of shares of Praxair Common Stock subject to such option immediately prior to the closing of the Business Combination and at a per-share exercise price equal to the per-share exercise price of Praxair's option.

Transaction history

JSON API

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction date	Company	Activity / security	Shares / units	Reported price	Reported value	Details
May 16, 2025 Filed May 20, 2025 15:33 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	1,987.16	$457.04	$908,211.61	Disclosure SEC source: 0001707925-25-000071 · wk-form4_1747769605.xml · nonDerivative · entry 1 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Indirect · In Family Trust Disclosed balance after: 22,639.04 F1 · price: The price reported is the weighted average sale price per share. The sale prices ranged from $456.94 to $457.14 per share. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:07 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionRestricted Stock Units · Derivative	1,180	$0.00	$0.00	Disclosure SEC source: 0001707925-25-000055 · wk-form4_1741738065.xml · derivative · entry 13 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,180 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis. F6 · derivative.exercise_date: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis. F6 · derivative.expiration_date: Restricted Stock Units that will vest in full and payout on or about March 7, 2025 in Linde plc Ordinary Shares on a one-for-one basis. Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:07 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionPerformance Share Units (RTSR) · Derivative	2,171	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001707925-25-000055 · wk-form4_1741738065.xml · derivative · entry 12 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,171 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The PSU paid out on March 10, 2025, and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2022-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022. F5 · derivative.expiration_date: The PSU paid out on March 10, 2025, and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2022-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022. Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:07 UTC	LINDE PLC LIN · Entity 2835	GrantPerformance Share Units (RTSR) · Derivative	2,171	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001707925-25-000055 · wk-form4_1741738065.xml · derivative · entry 11 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,171 Underlying: Ordinary Shares · 2,171 shares Expires not disclosed F5 · derivative.exercise_date: The PSU paid out on March 10, 2025, and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2022-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022. F5 · derivative.expiration_date: The PSU paid out on March 10, 2025, and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2022-2025 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022. Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:07 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionPerformance Share Units (ROC) · Derivative	3,530	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001707925-25-000055 · wk-form4_1741738065.xml · derivative · entry 10 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,530 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: The PSU paid out on March 10, 2025, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2022-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022. F4 · derivative.expiration_date: The PSU paid out on March 10, 2025, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2022-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022. Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:07 UTC	LINDE PLC LIN · Entity 2835	GrantPerformance Share Units (ROC) · Derivative	3,530	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001707925-25-000055 · wk-form4_1741738065.xml · derivative · entry 9 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,530 Underlying: Ordinary Shares · 3,530 shares Expires not disclosed F4 · derivative.exercise_date: The PSU paid out on March 10, 2025, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2022-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022. F4 · derivative.expiration_date: The PSU paid out on March 10, 2025, and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2022-2025 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted on March 7, 2022. Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:07 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	1,110.467	$468.77	$520,553.62	Disclosure SEC source: 0001707925-25-000055 · wk-form4_1741738065.xml · nonDerivative · entry 6 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,688.993 F2 · shares: Ordinary shares withheld from the payout to cover tax withholdings. Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:07 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	2,171	$0.00	$0.00	Disclosure SEC source: 0001707925-25-000055 · wk-form4_1741738065.xml · nonDerivative · entry 5 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,799.46 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2022. Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:07 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	1,805.596	$468.77	$846,409.24	Disclosure SEC source: 0001707925-25-000055 · wk-form4_1741738065.xml · nonDerivative · entry 4 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,628.46 F2 · shares: Ordinary shares withheld from the payout to cover tax withholdings. Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:07 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	3,530	$0.00	$0.00	Disclosure SEC source: 0001707925-25-000055 · wk-form4_1741738065.xml · nonDerivative · entry 3 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,434.056 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 7, 2022. Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:07 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	575.841	$468.77	$269,936.99	Disclosure SEC source: 0001707925-25-000055 · wk-form4_1741738065.xml · nonDerivative · entry 2 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,904.056 F2 · shares: Ordinary shares withheld from the payout to cover tax withholdings. Read SEC document
March 10, 2025 Filed Mar 11, 2025 20:07 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	1,180	$0.00	$0.00	Disclosure SEC source: 0001707925-25-000055 · wk-form4_1741738065.xml · nonDerivative · entry 1 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,479.897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 7, 2022. Read SEC document
March 07, 2025 Filed Mar 11, 2025 20:07 UTC	LINDE PLC LIN · Entity 2835	GrantStock Options (right to buy) · Derivative	8,973	$0.00 Strike: $468.77	$0.00	Disclosure SEC source: 0001707925-25-000055 · wk-form4_1741738065.xml · derivative · entry 17 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,973 Underlying: Ordinary Shares · 8,973 shares Expires 2035-03-07 F10 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2026. Read SEC document
March 07, 2025 Filed Mar 11, 2025 20:07 UTC	LINDE PLC LIN · Entity 2835	GrantRestricted Stock Units · Derivative	1,278	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001707925-25-000055 · wk-form4_1741738065.xml · derivative · entry 14 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,278 Underlying: Ordinary Shares · 1,278 shares Expires not disclosed F7 · derivative.exercise_date: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis. F7 · derivative.expiration_date: Restricted Stock Units that will vest in full and payout on or about March 7, 2028 in Linde plc Ordinary Shares on a one-for-one basis. Read SEC document
March 03, 2025 Filed Mar 4, 2025 15:01 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionStock Options (right to buy) · Derivative	7,545	$0.00 Strike: $154.00	$0.00	Disclosure SEC source: 0001707925-25-000019 · wk-form4_1741118452.xml · derivative · entry 15 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,545 Underlying: Ordinary Shares · 7,545 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: This option vested in full three years after the grant date. Read SEC document
March 03, 2025 Filed Mar 4, 2025 15:01 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	2,477	$469.74	$1,163,545.98	Disclosure SEC source: 0001707925-25-000019 · wk-form4_1741118452.xml · nonDerivative · entry 3 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,299.897 F2 · price: The price reported is the weighted average sale price. The sale prices ranged from $469.72 to $469.95. Upon request of the SEC Staff, Linde plc or a security holder of the issuer, the reporting person will provide full information regarding the number of shares sold at each separate price. Read SEC document
March 03, 2025 Filed Mar 4, 2025 15:01 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	5,068	$469.95	$2,381,706.60	Disclosure SEC source: 0001707925-25-000019 · wk-form4_1741118452.xml · nonDerivative · entry 2 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,776.897 F1 · shares: Ordinary shares withheld to cover exercise price and tax withholdings. Read SEC document
March 03, 2025 Filed Mar 4, 2025 15:01 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	7,545	$154.00	$1,161,930.00	Disclosure SEC source: 0001707925-25-000019 · wk-form4_1741118452.xml · nonDerivative · entry 1 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,844.897 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
December 20, 2024 Filed Dec 26, 2024 14:33 UTC	LINDE PLC LIN · Entity 2835	GiftOrdinary Shares	24,626.2	$0.00	$0.00	Disclosure SEC source: 0001707925-24-000117 · wk-form4_1735241579.xml · nonDerivative · entry 2 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Indirect · In Family Trust Disclosed balance after: 24,626.2 F1 · shares: The reporting person transferred for no consideration 24,626.2 Ordinary Shares to a Family Trust for the benefit of family members. As a result, the reporting person's beneficial ownership in the 24,626.2 shares changed from Direct to Indirect through the Family Trust. No market transactions were involved. Read SEC document
December 20, 2024 Filed Dec 26, 2024 14:33 UTC	LINDE PLC LIN · Entity 2835	GiftOrdinary Shares	24,626.2	$0.00	$0.00	Disclosure SEC source: 0001707925-24-000117 · wk-form4_1735241579.xml · nonDerivative · entry 1 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,299.897 F1 · shares: The reporting person transferred for no consideration 24,626.2 Ordinary Shares to a Family Trust for the benefit of family members. As a result, the reporting person's beneficial ownership in the 24,626.2 shares changed from Direct to Indirect through the Family Trust. No market transactions were involved. Read SEC document
December 16, 2024 Filed Dec 17, 2024 15:53 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	2,218	$434.35	$963,388.30	Disclosure SEC source: 0001707925-24-000115 · wk-form4_1734468811.xml · nonDerivative · entry 1 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,926.097 Read SEC document
March 11, 2024 Filed Mar 14, 2024 09:39 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionRestricted Stock Units · Derivative	1,515	$0.00	$0.00	Disclosure SEC source: 0001707925-24-000084 · wk-form4_1710423557.xml · derivative · entry 12 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,515 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_price: Restricted Stock Units that vested in full and paid out on March 11, 2024 in Linde plc Ordinary Shares on a one-for-one basis. F6 · derivative.exercise_date: Restricted Stock Units that vested in full and paid out on March 11, 2024 in Linde plc Ordinary Shares on a one-for-one basis. F6 · derivative.expiration_date: Restricted Stock Units that vested in full and paid out on March 11, 2024 in Linde plc Ordinary Shares on a one-for-one basis. Read SEC document
March 11, 2024 Filed Mar 14, 2024 09:39 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionPerformance Stock Units · Derivative	2,480	$0.00	$0.00	Disclosure SEC source: 0001707925-24-000084 · wk-form4_1710423557.xml · derivative · entry 11 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,480 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2021-2023 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021. F5 · derivative.exercise_date: The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual total shareholder return ("TSR") of Linde plc from 2021-2023 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021. F5 · derivative.expiration_date: The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual total shareholder return ("TSR") of Linde plc from 2021-2023 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021. Read SEC document
March 11, 2024 Filed Mar 14, 2024 09:39 UTC	LINDE PLC LIN · Entity 2835	GrantPerformance Stock Units · Derivative	2,480	$0.00	$0.00	Disclosure SEC source: 0001707925-24-000084 · wk-form4_1710423557.xml · derivative · entry 10 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,480 Underlying: Ordinary Shares · 2,480 shares Expires not disclosed F4 · derivative.exercise_price: The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2021-2023 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021. F5 · derivative.exercise_date: The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual total shareholder return ("TSR") of Linde plc from 2021-2023 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021. F5 · derivative.expiration_date: The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual total shareholder return ("TSR") of Linde plc from 2021-2023 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021. Read SEC document
March 11, 2024 Filed Mar 14, 2024 09:39 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionPerformance Stock Units · Derivative	4,540	$0.00	$0.00	Disclosure SEC source: 0001707925-24-000084 · wk-form4_1710423557.xml · derivative · entry 9 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,540 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_price: The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2021-2023 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021. F4 · derivative.exercise_date: The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2021-2023 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021. F4 · derivative.expiration_date: The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2021-2023 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021. Read SEC document
March 11, 2024 Filed Mar 14, 2024 09:39 UTC	LINDE PLC LIN · Entity 2835	GrantPerformance Stock Units · Derivative	4,540	$0.00	$0.00	Disclosure SEC source: 0001707925-24-000084 · wk-form4_1710423557.xml · derivative · entry 8 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,540 Underlying: Ordinary Shares · 4,540 shares Expires not disclosed F4 · derivative.exercise_price: The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2021-2023 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021. F4 · derivative.exercise_date: The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2021-2023 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021. F4 · derivative.expiration_date: The PSU paid out on March 11, 2024 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2021-2023 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2021. Read SEC document
March 11, 2024 Filed Mar 14, 2024 09:39 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	739.32	$462.55	$341,972.47	Disclosure SEC source: 0001707925-24-000084 · wk-form4_1710423557.xml · nonDerivative · entry 6 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,144.097 F2 · shares: Ordinary shares withheld from the payout to cover tax withholdings. Read SEC document
March 11, 2024 Filed Mar 14, 2024 09:39 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	1,515	$0.00	$0.00	Disclosure SEC source: 0001707925-24-000084 · wk-form4_1710423557.xml · nonDerivative · entry 5 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,883.417 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · shares: Ordinary shares acquired pursuant to the payout of a restricted stock unit grant made on March 8, 2021. Read SEC document
March 11, 2024 Filed Mar 14, 2024 09:39 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	1,268.52	$462.55	$586,753.93	Disclosure SEC source: 0001707925-24-000084 · wk-form4_1710423557.xml · nonDerivative · entry 4 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,368.417 F2 · shares: Ordinary shares withheld from the payout to cover tax withholdings. Read SEC document
March 11, 2024 Filed Mar 14, 2024 09:39 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	2,480	$0.00	$0.00	Disclosure SEC source: 0001707925-24-000084 · wk-form4_1710423557.xml · nonDerivative · entry 3 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,636.937 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 8, 2021. Read SEC document
March 11, 2024 Filed Mar 14, 2024 09:39 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	2,322.21	$462.55	$1,074,138.24	Disclosure SEC source: 0001707925-24-000084 · wk-form4_1710423557.xml · nonDerivative · entry 2 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,156.937 F2 · shares: Ordinary shares withheld from the payout to cover tax withholdings. Read SEC document
March 11, 2024 Filed Mar 14, 2024 09:39 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	4,540	$0.00	$0.00	Disclosure SEC source: 0001707925-24-000084 · wk-form4_1710423557.xml · nonDerivative · entry 1 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,479.147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · shares: Ordinary shares acquired pursuant to the payout of a performance share unit ("PSU") grant made on March 8, 2021. Read SEC document
March 07, 2024 Filed Mar 11, 2024 16:51 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionStock Options (right to buy) · Derivative	7,545	$0.00 Strike: $154.00	$0.00	Disclosure SEC source: 0001707925-24-000043 · wk-form4_1710190279.xml · derivative · entry 16 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,090 Underlying: Ordinary Shares · 7,545 shares Expires 2028-02-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F13 · derivative.exercise_date: This option vested in full three years after the grant date. Read SEC document
March 07, 2024 Filed Mar 11, 2024 16:51 UTC	LINDE PLC LIN · Entity 2835	GrantStock Options (right to buy) · Derivative	8,010	$0.00 Strike: $465.29	$0.00	Disclosure SEC source: 0001707925-24-000043 · wk-form4_1710190279.xml · derivative · entry 10 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,010 Underlying: Ordinary Shares · 8,010 shares Expires 2034-03-07 F7 · derivative.exercise_date: This option vests over three years in three consecutive equal annual installments beginning on March 7, 2025. Read SEC document
March 07, 2024 Filed Mar 11, 2024 16:51 UTC	LINDE PLC LIN · Entity 2835	GrantRestricted Stock Units · Derivative	1,235	$0.00	$0.00	Disclosure SEC source: 0001707925-24-000043 · wk-form4_1710190279.xml · derivative · entry 6 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,235 Underlying: Ordinary Shares · 1,235 shares Expires not disclosed F2 · derivative.exercise_price: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis. F2 · derivative.exercise_date: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis. F2 · derivative.expiration_date: Restricted Stock Units that will vest in full and payout on or about March 7, 2027 in Linde plc Ordinary Shares on a one-for-one basis. Read SEC document
March 07, 2024 Filed Mar 11, 2024 16:51 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	1	$466.32	$466.32	Disclosure SEC source: 0001707925-24-000043 · wk-form4_1710190279.xml · nonDerivative · entry 4 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,939.147 Read SEC document
March 07, 2024 Filed Mar 11, 2024 16:51 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	2,522	$465.65	$1,174,369.30	Disclosure SEC source: 0001707925-24-000043 · wk-form4_1710190279.xml · nonDerivative · entry 3 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,940.147 Read SEC document
March 07, 2024 Filed Mar 11, 2024 16:51 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	5,022	$466.15	$2,341,005.30	Disclosure SEC source: 0001707925-24-000043 · wk-form4_1710190279.xml · nonDerivative · entry 2 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,462.147 F1 · shares: Ordinary shares withheld to cover the exercise cost and tax withholdings. Read SEC document
March 07, 2024 Filed Mar 11, 2024 16:51 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	7,545	$154.00	$1,161,930.00	Disclosure SEC source: 0001707925-24-000043 · wk-form4_1710190279.xml · nonDerivative · entry 1 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,484.147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document
May 15, 2023 Filed May 17, 2023 12:36 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionStock Options (right to buy) · Derivative	6,605	$0.00 Strike: $118.71	$0.00	Disclosure SEC source: 0001062993-23-011297 · form4.xml · derivative · entry 15 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 6,605 shares Expires 2027-02-28 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders F11 · derivative.exercise_date: This option vested in full over three years in three consecutive equal annual installments beginning one year after the date of the grant. Read SEC document
May 15, 2023 Filed May 17, 2023 12:36 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	6	$370.77	$2,224.62	Disclosure SEC source: 0001062993-23-011297 · form4.xml · nonDerivative · entry 4 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,939.147 F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders Read SEC document
May 15, 2023 Filed May 17, 2023 12:36 UTC	LINDE PLC LIN · Entity 2835	SaleOrdinary Shares	2,188	$371.02	$811,791.76	Disclosure SEC source: 0001062993-23-011297 · form4.xml · nonDerivative · entry 3 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,945.147 F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders Read SEC document
May 15, 2023 Filed May 17, 2023 12:36 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	4,411	$371.23	$1,637,495.53	Disclosure SEC source: 0001062993-23-011297 · form4.xml · nonDerivative · entry 2 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,133.147 F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders F2 · shares: Shares of common stock withheld to cover the exercise cost and tax withholdings. Read SEC document
May 15, 2023 Filed May 17, 2023 12:36 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionOrdinary Shares	6,605	$118.71	$784,079.55	Disclosure SEC source: 0001062993-23-011297 · form4.xml · nonDerivative · entry 1 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,544.147 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders Read SEC document
March 10, 2023 Filed Mar 13, 2023 13:08 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionRestricted Stock Units · Derivative	1,715	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001062993-23-006704 · form4.xml · derivative · entry 15 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 1,715 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders F2 · derivative.exercise_price: Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 9, 2020. F2 · derivative.exercise_date: Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 9, 2020. F2 · derivative.expiration_date: Shares of common stock acquired pursuant to the payout of a restricted stock unit grant made on March 9, 2020. Read SEC document
March 10, 2023 Filed Mar 13, 2023 13:08 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionPerformance Share Units · Derivative	2,790	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001062993-23-006704 · form4.xml · derivative · entry 11 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 2,790 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders F5 · derivative.exercise_price: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020. F5 · derivative.exercise_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020. F5 · derivative.expiration_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020. Read SEC document
March 10, 2023 Filed Mar 13, 2023 13:08 UTC	LINDE PLC LIN · Entity 2835	GrantPerformance Share Units · Derivative	2,790	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001062993-23-006704 · form4.xml · derivative · entry 10 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,790 Underlying: Ordinary Shares · 2,790 shares Expires not disclosed F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders F5 · derivative.exercise_price: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020. F5 · derivative.exercise_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020. F5 · derivative.expiration_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the total shareholder return ("TSR") of Linde plc from 2020-2022 measured against TSR goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020. Read SEC document
March 10, 2023 Filed Mar 13, 2023 13:08 UTC	LINDE PLC LIN · Entity 2835	Exercise / conversionPerformance Share Units · Derivative	5,150	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001062993-23-006704 · form4.xml · derivative · entry 9 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 5,150 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders F4 · derivative.exercise_price: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020. F4 · derivative.exercise_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020. F4 · derivative.expiration_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020. Read SEC document
March 10, 2023 Filed Mar 13, 2023 13:08 UTC	LINDE PLC LIN · Entity 2835	GrantPerformance Share Units · Derivative	5,150	$0.00 Strike: $0.00	$0.00	Disclosure SEC source: 0001062993-23-006704 · form4.xml · derivative · entry 8 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,150 Underlying: Ordinary Shares · 5,150 shares Expires not disclosed F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders F4 · derivative.exercise_price: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020. F4 · derivative.exercise_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020. F4 · derivative.expiration_date: The PSU paid out on March 10, 2023 and the number of shares awarded and paid out was determined based upon the average annual return on capital ("ROC") of Linde plc from 2020-2022 measured against ROC goals set by the Human Capital Committee of the Board of Directors when the PSU was granted in 2020. Read SEC document
March 10, 2023 Filed Mar 13, 2023 13:08 UTC	LINDE PLC LIN · Entity 2835	Tax withholdingOrdinary Shares	1,428	$345.92	$493,973.76	Disclosure SEC source: 0001062993-23-006704 · form4.xml · nonDerivative · entry 6 Strauss David P · CIK 0001705851 · Executive VP, Chief HR Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,730.42 F1 · security: On March 1, 2023, Linde plc (formerly Rounderway plc), an Irish public limited company ("New Linde"), became the successor of Linde plc, an Irish public limited company ("Old Linde"), pursuant to a scheme of arrangement and merger under Irish law. Pursuant to the scheme of arrangement, all outstanding ordinary shares of Old Linde were exchanged, on a one-for-one basis, for ordinary shares of New Linde, and Old Linde subsequently merged into New Linde and ceased to exist. The transaction did not alter the relative interests of security holders F3 · shares: Shares of common stock withheld from the payout to cover tax withholdings. Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.